MedTrace Logo

Evaluating Ketamine and Psychological Sequelae

NCT04053400 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 159

Last updated 2019-08-12

No results posted yet for this study

Summary

The purpose of this study is to examine the relationship between the use of intravenous infusion of sub-anesthetic dosages of ketamine given for pain to combat casualties and emerging symptoms of Post-Traumatic Stress Disorder (PTSD), depression, anxiety, sleep disruption, and risk of alcohol abuse as identified with behavioral health screening tools. Although ketamine has gained popularity as an analgesic agent, literature related to its psychological impact is sparse.

Conditions

  • Pain, Ketamine Infusion, Psychologic Sequelae

Interventions

DRUG

Ketamine

Sponsors & Collaborators

  • Defense and Veterans Center for Integrative Pain Management

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-12-31
Primary Completion
2017-09-30
Completion
2017-09-13

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04053400 on ClinicalTrials.gov